Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-05-03
1999-02-23
Crouch, Deborah
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514885, A61K 3800
Patent
active
058744045
ABSTRACT:
Disclosed is an antiallergic composition comprising, as an active ingredient, a peptide which is capable of binding to human IgE, more specifically the high-affinity immunoglobulin E receptor .alpha.-chain or a soluble fragment, which is capable of binding to human IgE, or the high-affinity immunoglobulin E receptor .alpha.-chain. The composition is clinically useful for blocking allergic responses. An animal model for use in the screening of prophylactic and therapeutic compositions for IgE-related diseases is also disclosed.
REFERENCES:
patent: 4962035 (1990-10-01), Leder
patent: 5011795 (1991-04-01), Levinson et al.
Stites et al Basic & Clinical Immunology, 1984 pp. 234, 242, Nov. 7, 1997.
P. 21, Basic and Clinical Immunology 1984.
Ra et al. Internal Immunology 5(1): 47, 1993.
Blark et al JBC 266(4): 2639, 1991.
Kochon et al NAR 16(8): 3584, 1988.
The Journal of Biological Chemistry, vol. 266, No. 4 (1991), U.Blank et al., "Characterization of truncated a chain products from human, rat, and mouse high affinity receptor for immunoglobulin E", pp. 2639-2646.
Nucleic Acids Research, vol. 16, No. 8 (1988), J. Kochan et al., "Isolation of the gene coding for the alpha subunit of the human high affinity IgE receptor" p. 3584.
Nucleic Acids Research, vol. 13, No. 8 (1985), Andrea Riccio et al., "The human urokinase-plasminogen activator gene and its Promoter" pp. 2759-2771.
Biosci. Biotech. Biochem., vol. 56, No. 4 (1992), T. Yamauchi et al., "Production of human antithrombin-III in a serum-free culture of CHO cells" pp. 600-604.
Chemical Abstracts, vol. 112, No. 23, Jun. 4, 1990, Columbus, Ohio, USA, "Preparation of immunoglobulin E peptide fragments as allergy inhibitors" p. 708, col. 1, No. 217 552x.
Chemical Abstracts, vol. 121, No. 13, Sep. 26, 1994, Columbus, Ohio, USA "Preparation of peptides with binding activity to human immunoglobulin E" p. 1086, col. 1, No. 158 211w.
Journal of Immunology, vol. 153, No. 8, 15 Oct. 1994, Balt., US, pp. 3804-3810.
Cellular Immunology, vol. 151, No. 2, 15 Oct. 1993, pp. 241-256.
Journal of Immunology, vol. 148, No. 4, 15 Feb. 1992, Balt., US, pp. 1065-1071.
M.C. Ray, et al., J. Immunol., 131(3): 1096-1102 (1983).
U. Blank, et al., J. Biol. Chem., 266(4), 2639-2646 (1991).
C. Ra, et al., International Immunology, 5(1), 47-54 (1993).
U.S. application No. 07/626704, Kinet et al., filed Dec. 14, 1990.
U.S. application No. 07/547892, Kinet, filed Feb. 7, 1990.
Hirama Minoru
Naito Koji
Okumura Ko
Ra Chisei
Yanagihara Yukiyoshi
Beckerleg Anne Marie S.
Crouch Deborah
Ra Chisei
The Green Cross Corporation
LandOfFree
Immunoglobulin E receptor .alpha.-chain inhibits IgE production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoglobulin E receptor .alpha.-chain inhibits IgE production , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoglobulin E receptor .alpha.-chain inhibits IgE production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-306932